Animal model of Parkinson's disease induced by naturally-occurring 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline

Biogenic Amines

Volumn 12, Issue 2, 1996, Pages 135-147

  Naoi, M ^a   Maruyama, W ^b   Dostert, P ^c   Hashizume, Y ^d  

^a NAGOYA INSTITUTE OF TECHNOLOGY   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Pharmacia   (Italy)

^d AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

1,2 dimethyl 6,7 dihydroxy 1,2,3,4 tetrahydroisquinoline; Animal model; Enantiometric specificity; Parkinson's disease; Salsolinol; Tyrosine hydroxylase

Indexed keywords

1,2N DIMETHYL 6,7 DIHYDROXY 1,2,3,4 TETRAHYDROISOQUINOLONE; ACETALDEHYDE; ANTIBODY; DOPAMINE; EPININE; NORADRENALIN; TETRAHYDROISOQUINOLINE DERIVATIVE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BIOCHEMISTRY; CELL DENSITY; CONTINUOUS INFUSION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; ENZYME ISOLATION; IMMUNOHISTOCHEMISTRY; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NONHUMAN; OXIDATION; PARKINSONISM; PATHOGENESIS; RAT; SUBSTANTIA NIGRA;

ANIMALIA;

EID: 0030011365     PISSN: 01688561     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bembenek, M. E., Abell, C. W., Chrisey, L. A., Rozwadoeska, M. D., Gesner, W. and Brossi, A. (1990) Inhibition of monoamine oxidases A and by simple isoquinoline alkaloids; racemic and optimally active 1,2,3,4-tetrahydro-3,4-dihydro-, and fully aromatic isoquinolines. J. Med. Chem., 33: 147-152.
2. Chiba , K., Trevor, A. J., and Castagnoli, N. (1984) Metabolism of the neurotoxic amine, MPTP by brain monoamine oxidase. Biochem. Biophys. Res. Commun., 120: 574-578.
3. Collins, M. A. and Cheng B. Y. (1988) Oxidative decarboxylation of salsolinol-1-carboxylic acid to 1,2-dehydrosalsolinol: Evidence for exclusive catalysis by particular factors in rat kidney. Arch. Biochem. Biophys., 263: 86-96.
4. Deng, Y., Maruyama, W., Dostert, P., Takahashi, T., M. Kawai and Naoi, M. (1995) Determination of the (R)- and (S)-enantiomers of salsolinol and N-methylsalsolinol by use of a chiral high-performance liquid chromatography. J. Chromatogr. B., 670: 47-54.
5. Dostert, P., Strolin Benedetti, M. and Dordain, G. (1988) Dopamine-derived alkaloids in alcoholism and in Parkinson's and Huntington's diseases. J. Neural Transm., 74: 61-74.
6. Heikkila, R. E., Manzino, L., Cabbat, F. S. and Duvoisin, R. C. (1984) Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine by monoamine oxidase inhibitor. Nature 311: 467-469.
7. Homykiewicz, O. and Kish, S. (1986) Biochemical pathophysiology of Parkinson's disease. Adv. Neurol., 45: 19-32.
8. Maruyama, W., Nakahara, D., Ota, M., Takahashi, T., Takahashi, T., Nagatsu, T. and Naoi, M. (1992) N-Methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains; in vivo microdialysis. J. Neurochem., 59: 395-400.
9. Maruyama, W., Nakahara, D. Dostert, P., Hashiguchi, H. Ohta, S., Hirobe, M., Takahashi, A., Nagatsu, T. and Naoi, M. (1993) Selective release of serotonin by endogenous alkaloids, 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines, (R)- and (S)salsolinol, in the rat striatum; in vivo microdialysis study. Neurosci. Lett., 149: 115-118.
10. Maruyama, W. and Naoi, M. (1994) Inhibition of tyrosine hydroxylase by a dopamine neurotoxin, 1-methyl-4-phenylpyridinium ion: Depletion of allostery to the biopterin cofactor. Life Sci., 55: 207-212.
11. Maruyama, W., Nakahara, D., Dostert, P., Takahashi, T. and Naoi, M. (1995a) Dopamine-derived isoquinolines as dopaminergic neurotoxins and oxidative stress. In: Alzheimer's and Parkinson's Diseases; Recent Advances. J. Hanin, M. Yoshida and A. Fisher (Eds.), Plenum, New York and London, pp. 575-581.
12. Maruyama W., Dostert, P. and Naoi, M. (1995b) Dopamine-derived 1-methyl-6,7-dihydroxyisoquinolines as hydroxyl radical promoters and scavengers in the rat brain: In vivo and in vitro studies. J Neurochem., 64: 2635-2643.
13. Maruyama, W., P. Dostert, P., Matsubara, K. and Naoi, M. (1995c) N-Methyl(R)salsolinol produces hydroxyl radicals; Involvement to neurotoxicity. Free Rad. Biol. Med., 19: 67-75.
14. Matsubara, K., Collins, M. A., Akane, A., Ikebuchi, J., Neafsey, E. J., Kagawa, M. and Shiono, H. (1993) Potential bioactivated neurotoxins, N-methylated β-carbolinium tons, are present in human brain. Brain Res., 610: 90-96.
15. Naoi, M., Matsuura, S., Takahashi, T. and Nagatsu, T. (1989) An N-methyltransferase in human brain catalyzes N-methylation of 1,2,3,4-tetrahydroisoquinoline into N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin, N-methylisoquinolinium ion. Biochem. Biophys. Res. Commun., 161: 1213-1219.
16. Naoi, M., Dostert, P., Yoshida, M. and Nagatsu T. (1993a) N-Methylated tetrahydroisoquinolines as dopaminergic neurotoxins. Adv. Neurol., 60: 212-217.
17. Naoi, M., Maruyama, W., Acworth, I. N., Nakahara, D. and Parvez, H. (1993b) Multi-electrode detection system for determination of neurotransmitters. In: Methods in Neurotransmitter and Neuropeptide Research, Part 1. S. H. Parvez, M. Naoi, T. Nagatsu and S. Parvez (Eds.), Elsevier, Amsterdam, pp. 1-39.
18. Naoi, M., Maruyama, W. and Dostert, P. (1994a) Binding of 1,2(N)-dimethyl-6,7-dihydroxy-isoquinolinium ion to melanin: effects of ferrous and ferric ion on the binding. Neurosci. Lett., 171: 9-12.
19. Naoi, M., Maruyama, W., Niwa, T. and Nagatsu, T. (1994b) Novel toxins and Parkinson's disease: N-methylation and oxidation as metabolic bioactivation of neurotoxin. J. Neural Transm. [Suppl.], 41: 197-205.
20. Naoi, M., Maruyama, W., Dostert, P., Nakahara, D., Takahashi, T. and Nagatsu, T. (1995a) Metabolic bioactivation of endogenous isoquinolines as dopaminergic neurotoxins to elicit Parkinson's disease. In: Alzheimer's and Parkinson's Diseases: Recent Advances, I. Hanin, M. Yoshida and A. Fisher (eds.), Plenum Publishing, New York and London, pp. 553-559.
21. Naoi, M., Maruyama, W., Zhang, J. P., Takahashi, T., Deng, Y. and Dostert, P. (1995b) Enzymatic oxidation of the dopaminergic neurotoxin, 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, into 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion. Life Sci., 11: 1061-1066.
22. Naoi, M., Maruyama, W. and Dosiert, P. (1995c) Dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines; oxidation and neurotoxicity. Progress Brain Res., 106:227-239.
23. Naoi, M., Maniyama, W., Dostert P., Hashizume, Y., Nakahara, D., Takahashi, T. and Ota, M. (1996) Dopamine-derived endogenous 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies. Brain Res., in press.
24. Niwa, T., Takeda, N., Yoshizumi, H., Tatematsu, A. Yoshida, M., Dostert, P., Naoi, M. and Nagatsu, T. (1991) Presence of 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, novel endogenous amines, in parkinsonian and normal human brains. Biochem. Biophys. Res. Commun., 177: 603-609.
25. Paxinos, G. and Watson, C., The rat brain in stereotaxic coordinates, Academic Press, Sidney, 1986
26. Riederer, P., Sofic, E., Rausch, W.-D., Schmidt, B., Reynolds, G. P., Jellinger, K. and Youdim, M. B. H. (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem., 52: 515-520.
27. Sällström Baum, S. and Rommelspracher, H. (1994) Determination of total dopamine, R - and S-salsolinol in human plasma by cyclodextrin bonded-phase liquid chromatography with electrochemical detection. J. Chromatogr. B., 660: 235-241.
28. Sandler, M., Carter, S. B., Hunter, K. R. and Stem, G. M. (1973) Tetrahydroisoquinoline alkaloids; in vivo metabolites of L-DOPA in man. Nature, 241: 439-443.
29. Singer, T. P., Castagnoli Jr., J. N. Ramsay, R. R. and Trevor, A. J. (1987) Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J. Neurochem., 49: 1-8.
30. Sjöquist, B., Eriksson, A. and Winblad, B. (1982a) Brain salsolinol levels in alcoholism. Lancet, i: 675-676.
31. Sjöquist, B., Eriksson, A. and Winblad, B. (1982b) Salsolinol and catecholamines in human brain and their relation to alcoholism. Prog. Clin. Biol. Res., 90: 56-67.
32. Strolin Benedetti, M., Bellotti, V., Poanezola, E., Carminati, P. and Dostert, P. (1989) Ratio of the R and S enantiomers of salsolinol in food and human urine. J. Neural Transm., 77: 47-53.
33. Takahashi, T., Y. Deng, Maruyama, W., Dostert, P., Kawai, M. and Naoi, M. (1994). Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system. J. Neural Transm. [GenSect], 98: 107-118.
34. Teitel, S., O'Brien, J. and Brossi, A. (1972) Alkaloids in mammalian tissue U. Synthesis of (+) and (-) substituted-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolanes. J. Med. Chem., 15: 845-846.
35. Tipton, K. F. and Singer T. P. (1993). Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem., 61: 1191-1206.